Fig. 3From: Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case reportBone marrow plasma cell immunophenotype by flow cytometry analysis. BCMA, B-cell maturation antigen; BMMC, bone marrow mast cells; FMO, fluorescence minus oneBack to article page